Irska - engleski - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - human fibrinogen; human thrombin; calcium chloride; aprotinin - solution for sealant - 4 ml - local hemostatics; tissue adhesives

Irska - engleski - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - human fibrinogen; human factor xiii; aprotinin; human thrombin; calcium chloride - powder and solvent for sealant - . - local hemostatics; tissue adhesives

Singapur - engleski - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - clottable protein (human fibrinogen); human thrombin - solution - 50-90 mg/ml - clottable protein (human fibrinogen) 50-90 mg/ml; human thrombin 800-1200 iu/ml

Malta - engleski - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, aprotinin, fibrinogen, human, thrombin - solution for sealant - calcium chloride 40 µmole/ml aprotinin 3000 kiu/ml fibrinogen, human 91 mg/ml thrombin, human 500 iu/mg - antihemorrhagics

Izrael - engleski - Ministry of Health

omrix biopharmaceuticals - human fibrinogen; human thrombin - solutions for sealant - human thrombin 500 iu / 1 ml; human fibrinogen 80 mg / 1 ml - human fibrinogen - supportive treatment in adults where standard surgical techniques are insufficient for improvement of haemostasis, and as suture support in vascular surgery

Singapur - engleski - HSA (Health Sciences Authority)

pharmeng technology pte. ltd. - human thrombin; human fibrinogen - sponge - 2.0 iu per sq cm - human thrombin 2.0 iu per sq cm; human fibrinogen 5.5 mg per sq cm

Izrael - engleski - Ministry of Health

csl behring ltd., israel - human fibrinogen - powder for solution for inj/inf - human fibrinogen 900 - 1300 mg / 1 vials - fibrinogen, human - fibrinogen, human - haemocomplettan p 1g/2g, fibrinogen concentrate (human) is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.haemocomplettan p 1g/2g is not indicated for dysfibrinogenemia.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

csl behring australia pty ltd - fibrinogen, quantity: 900 mg - injection, powder for - excipient ingredients: sodium citrate; albumin; arginine hydrochloride; sodium chloride - treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenaemia and hypofibrinogenaemia.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

corza medical gmbh - human thrombin (unii: 6k15abl77g) (human thrombin - unii:6k15abl77g), fibrinogen human (unii: n94833051k) (fibrinogen human - unii:n94833051k) - tachosil is a fibrin sealant patch indicated for use with manual compression in adult and pediatric patients as an adjunct to hemostasis in cardiovascular and hepatic surgery when control of bleeding by standard surgical techniques (such as suture, ligature or cautery) is ineffective or impractical. limitations for use do not use tachosil for: risk summary a review of available data suggests that major birth defects occur in 2-4% of the u.s. general population and that miscarriage occurs in 15-20% of clinically recognized pregnancies, regardless of drug exposure. animal reproduction studies have not been conducted with tachosil. there are no adequate and well-controlled studies in pregnant women. it is also not known whether tachosil can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. tachosil should be administered to pregnant women only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, ca

Kanada - engleski - Health Canada

corza medical gmbh - fibrinogen (human); thrombin (human); collagen - patch - 5.5mg; 2unit; 2.1mg - fibrinogen (human) 5.5mg; thrombin (human) 2unit; collagen 2.1mg - hemostatics